Open Trade
KPRXLong Stock
Entry comments: Sympathy play of KALA. Both looking to get a product out for a rare eye condition PCED. KALA got an IND approved recently to study their stem cell treatment while KRPX just finished enrolling patients for their eye bandage drops. KALA did have notably more short interest but looking to see FOMO drive into KRPX
Broker:Schwab
| Date | Price | |
|---|---|---|
| Entry | 1/5/2023 | 4.30 |
- Total Views33
- Position Size4,700
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
